Annji Pharmaceutical Co (ROCO:7754) Accounts Receivable : NT$0.15 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Annji Pharmaceutical Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Annji Pharmaceutical Co's accounts receivables for the quarter that ended in Dec. 2024 was NT$0.15 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Annji Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 1.60.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Annji Pharmaceutical Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was NT$4.06.

Annji Pharmaceutical Co Accounts Receivable Historical Data

The historical data trend for Annji Pharmaceutical Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annji Pharmaceutical Co Accounts Receivable Chart

Annji Pharmaceutical Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Accounts Receivable

0.09

0.15

Annji Pharmaceutical Co Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Receivable	Get a 7-Day Free Trial			0.09	-	-	-	0.15

Annji Pharmaceutical Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Annji Pharmaceutical Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Annji Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.147	/	16.719	*	91
=	1.60

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Annji Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Annji Pharmaceutical Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(706.011	+	0.75 * 0.147	+	0.5 * 27.416	-	339.904
-	0	-	0)	/	93.668
=	4.06

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Annji Pharmaceutical Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Annji Pharmaceutical Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Annji Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annji Pharmaceutical Co Ltd (ROCO:7754) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011

Website

https://www.ajpharm.com

Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.

Annji Pharmaceutical Co Headlines

No Headlines